Blue Trust Inc’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87.8K Buy
3,884
+330
+9% +$7.41K ﹤0.01% 1101
2026
Q1
$80.2K Sell
3,554
-1,422
-29% -$32.7K ﹤0.01% 1123
2025
Q4
$119K Sell
4,976
-644
-11% -$16K ﹤0.01% 973
2025
Q3
$148K Sell
5,620
-565
-9% -$14.5K ﹤0.01% 919
2025
Q2
$177K Buy
6,185
+2,216
+56% +$59.5K ﹤0.01% 813
2025
Q1
$98.8K Sell
3,969
-1,765
-31% -$42K ﹤0.01% 997
2024
Q4
$130K Sell
5,734
-7,129
-55% -$155K ﹤0.01% 823
2024
Q3
$246K Buy
12,863
+11,755
+1,061% +$231K ﹤0.01% 762
2024
Q2
$21.4K Buy
1,108
+383
+53% +$7.81K ﹤0.01% 1630
2024
Q1
$14K Buy
725
+24
+3% +$476 ﹤0.01% 1351
2023
Q4
$15K Sell
701
-1,217
-63% -$23.4K ﹤0.01% 1419
2023
Q3
$46K Buy
1,918
+99
+5% +$2.4K ﹤0.01% 872
2023
Q2
$39K Sell
1,819
-601
-25% -$13.8K ﹤0.01% 781
2023
Q1
$40K Sell
2,420
-946
-28% -$18.1K ﹤0.01% 1114
2022
Q4
$48K Buy
3,366
+3,098
+1,156% +$45.9K ﹤0.01% 931
2022
Q3
$7K Buy
268
+74
+38% +$1.4K ﹤0.01% 1465
2022
Q2
$6K Buy
+194
New +$5.8K ﹤0.01% 1375

Other funds holding FMS

Blue Trust Inc's FMS Position: Q2 2026 in Review

Blue Trust Inc increased its Fresenius Medical Care (FMS) stake by 9.3% in Q2 2026, buying an estimated $7.41K and bringing the position to 3,884 shares worth $87.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Blue Trust Inc first reported a position in FMS in Q2 2022 and has held it in 17 quarters since. The position peaked at $246K in Q3 2024. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Blue Trust Inc held 3,884 shares of Fresenius Medical Care worth $87.8K as of Q2 2026.
  • Blue Trust Inc bought 330 Fresenius Medical Care shares in Q2 2026, an estimated $7.41K.
  • Fresenius Medical Care made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1101 holding.
  • Blue Trust Inc first reported a position in Fresenius Medical Care in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Fresenius Medical Care position peaked at $246K in Q3 2024.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.